UPDATE 2-Chiron posts profit, writes off flu shot inventory
45398
Chiron Corp. (CHIR.O: Quote, Profile, Research) , barred from shipping its flu vaccine after it was found to be contaminated, on Wednesday posted a quarterly
72531
The Chiron Corporation, a major manufacturer of influenza vaccine, said that it had detected a contamination problem in its new supply and was delaying release of nearly 50 million doses.
682567
Merrill Lynch downgraded Chiron (nasdaq: CHIR - news - people ) to &quot;sell&quot; from &quot;neutral&quot; after news reports indicated a flu vaccine from GlaxoSmithKline (nyse: GSK - news - people ) could be approved by the US Food and Drug Administration as early as
134309
Chiron Corp., forced to halt shipment  on its flu vaccine because of manufacturing woes at its plant  in England, is the subject of an informal civil investigation  by U.S. regulators, the company said on Wednesday.
242494
The flu vaccine shortage has US companies bracing for a surge in costly sick days and lost productivity. The closure earlier this month of Chiron Corp.
594500
Schering-Plough Corp. SGP.N on  Thursday reported a quarterly profit after a year-ago loss, as  positive foreign exchange trends helped offset poor sales of  its allergy and hepatitis drugs.
222125
Shares of Chiron Corp., the world&#39;s second-biggest seller of influenza vaccines, fell as much as 9.5 percent after saying it would delay shipments of its Fluvirin flu shots until October because of a possible product flaw.
202202
The company that makes half the nation&#39;s supply, Chiron Corporation, has found four million tainted samples in its factory. It&#39;s postponing shipments of 50 million doses of vaccine until they&#39;re checked for safety.
741225
Chiron Corp. is delaying shipment of  its flu vaccine, Fluvirin,  because lots containing 4 million  vaccines, do not meet product sterility standards, the  pharmaceutical company said on Thursday .
567677
Chiron Corp. may begin ramping up for flu vaccine production before British and U.S. regulators have officially re-approved its manufacturing license, under a plan disclosed by Chief Executive Howard Pien on ...
595967
BOSTON (CBS.MW) -- Shares of embattled vaccine maker Chiron Corp. slipped notably Wednesday after it announced that UK regulatory authorities had extended a suspension on the company&#39;s license to manufacture at its primary flu vaccine-making facility.
136161
Emeryville-based Chiron Corp. said Tuesday that it will not be able to supply flu vaccine for this winter&#39;s flu season after Britain&#39;s Medicines and Healthcare Products Regulatory Agency (MHRA) temporarily
735045
Swiss vaccine maker Berna Biotech   expects flu vaccine sales to rise after Chiron was stopped from  selling a rival product, and it expects to reach its full-year  sales target, the company said on Wednesday.
113641
Chiron Corp. CHIR.O on Tuesday  slashed its 2004 earnings forecast after announcing that it  will not record any sales of its flu vaccine for the 2004-2005  flu season, sending its shares down 18 percent.
67567
Chiron (CHIR:Nasdaq - news - research) said Thursday that it had found some problems with the production of its Fluvirin influenza virus vaccine, which will cause a delay in the product&#39;s reaching the market until early October.
328299
Chiron Corp. is delaying shipment of its flu vaccine, Fluvirin, because lots containing 4 million vaccines, do not meet product sterility standards, the pharmaceutical company said on Thursday .
74243
Emeryville drug company Chiron Corp. said Friday it has gotten a warning letter from the US Food and Drug Administration about its flu vaccine manufacturing.